How Sleep Protects Your Stem Cells — and What Happens When You Don’t Get Enough

New 2026 research shows that uninterrupted sleep reprograms stem cells and suppresses mutant clone expansion. Here's what the science says about protecting your body's repair cells while you rest.

Читать далее...

MSC Therapy for Systemic Sclerosis: iPSC-Derived Stem Cells, Clinical Trials, and the Vasculopathy-Fibrosis Mechanism

A comprehensive 2026 review of mesenchymal stem cell therapy for systemic sclerosis (scleroderma), covering iPSC-derived MSCs, refrigerated cell delivery, blood vessel organoid models, and the MANUS clinical trial for digital ulcers.

Читать далее...

MSC Therapy for Parkinson’s Disease: What Randomized Trials and Comprehensive Reviews Reveal

Multiple 2026 clinical trials and reviews show mesenchymal stem cell therapy is safe and feasible for Parkinson's disease — but what do the actual data say about efficacy, dosing, and what comes next?

Читать далее...

MSC Therapy for Pediatric Acute GvHD: From FDA Approval to Next-Generation Approaches

The first FDA-approved MSC therapy (Ryoncil) ended a 20-year drought for cell-based products in the US. New real-world data from 139 children and next-generation platforms are reshaping how clinicians treat steroid-refractory pediatric GvHD.

Читать далее...

Can Stem Cell Therapy Help Children with Autism? What 2026 Research Shows

A double-blind RCT shows cord blood stem cells improved social cognition in children with autism. Here's what parents need to know about the latest research, safety data, and treatment process.

Читать далее...

MSC Therapy for Ischemic Stroke: What a 2026 Umbrella Review and Network Meta-Analysis of 1,006 Patients Reveal

The 2026 evidence base for mesenchymal stem cell therapy in ischemic stroke includes a 26-study umbrella review and an 18-RCT network meta-analysis of 1,006 patients. MSCs were the only cell type to significantly reduce mortality. This medical review synthesizes the latest clinical data, mechanisms, active trials, and translational barriers.

Читать далее...

Терапия мезенхимальными стволовыми клетками при рассеянном склерозе: что показывают 17 клинических испытаний?

МСК являются наиболее перспективным методом клеточной терапии при прогрессирующем рассеянном склерозе, и в 2026 году появились статьи о механизме действия и результаты одного хорошо контролируемого исследования, которые, наконец, подтверждают это. Вот что означают 17 исследований, SMART-MS и новые работы по микроРНК для реальных пациентов.

Читать далее...

Harnessing MSC-Derived Exosomes for Advanced Rheumatoid Arthritis Immunotherapy

Discover the groundbreaking potential of MSC-derived exosomes in revolutionizing Rheumatoid Arthritis immunotherapy. Learn about novel nanoplatforms and their mechanism of action.

Читать далее...

Stem Cell Therapy for Osteoporosis: What 2026 Research Means for Women After Menopause

Osteoporosis after menopause affects millions of women. New 2026 research shows mesenchymal stem cells and exosomes can rebuild bone density safely. Here’s what patients need to know.

Читать далее...

MSC Therapy for Burn Wounds and Chronic Skin Regeneration: 2026 Breakthroughs in Exosome-Based Healing

New 2026 research reveals UC-MSC exosomes combined with low-intensity pulsed ultrasound and curcumin-hydrogel systems achieve remarkable burn wound healing — including MRSA-infected wounds — through autophagy regulation, anti-scarring mechanisms, and immunomodulation. Five landmark papers reviewed.

Читать далее...
Вершина